Genelux Corporation (GNLX)
Genelux Statistics
Share Statistics
Genelux has 34.54M shares outstanding. The number of shares has increased by 29.27% in one year.
Shares Outstanding | 34.54M |
Shares Change (YoY) | 29.27% |
Shares Change (QoQ) | 0.01% |
Owned by Institutions (%) | n/a |
Shares Floating | 30.04M |
Failed to Deliver (FTD) Shares | 4.1K |
FTD / Avg. Volume | 1.94% |
Short Selling Information
The latest short interest is 1.43M, so 4.15% of the outstanding shares have been sold short.
Short Interest | 1.43M |
Short % of Shares Out | 4.15% |
Short % of Float | 4.77% |
Short Ratio (days to cover) | 8.9 |
Valuation Ratios
The PE ratio is -12.1 and the forward PE ratio is -3.31. Genelux's PEG ratio is -0.03.
PE Ratio | -12.1 |
Forward PE | -3.31 |
PS Ratio | 2013.26 |
Forward PS | 1.1 |
PB Ratio | 17.58 |
P/FCF Ratio | -16.07 |
PEG Ratio | -0.03 |
Enterprise Valuation
Genelux Corporation has an Enterprise Value (EV) of 335.36M.
EV / Earnings | -11.85 |
EV / Sales | 1972.68 |
EV / EBITDA | -12.68 |
EV / EBIT | -13.88 |
EV / FCF | -15.74 |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.13.
Current Ratio | 3.69 |
Quick Ratio | 3.69 |
Debt / Equity | 0.13 |
Total Debt / Capitalization | 11.45 |
Cash Flow / Debt | -8.05 |
Interest Coverage | -6.08 |
Financial Efficiency
Return on equity (ROE) is -1.45% and return on capital (ROIC) is -109.88%.
Return on Equity (ROE) | -1.45% |
Return on Assets (ROA) | -1.01% |
Return on Capital (ROIC) | -109.88% |
Revenue Per Employee | 6.8K |
Profits Per Employee | -1.13M |
Employee Count | 25 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -42.64% in the last 52 weeks. The beta is -1.51, so Genelux's price volatility has been lower than the market average.
Beta | -1.51 |
52-Week Price Change | -42.64% |
50-Day Moving Average | 3.5 |
200-Day Moving Average | 2.78 |
Relative Strength Index (RSI) | 48.13 |
Average Volume (20 Days) | 211.78K |
Income Statement
In the last 12 months, Genelux had revenue of 170K and earned -28.3M in profits. Earnings per share was -1.16.
Revenue | 170K |
Gross Profit | -848K |
Operating Income | -24.16M |
Net Income | -28.3M |
EBITDA | -26.46M |
EBIT | -24.16M |
Earnings Per Share (EPS) | -1.16 |
Balance Sheet
The company has 9.42M in cash and 2.52M in debt, giving a net cash position of 6.9M.
Cash & Cash Equivalents | 9.42M |
Total Debt | 2.52M |
Net Cash | 6.9M |
Retained Earnings | -221.52M |
Total Assets | 40.27M |
Working Capital | 30.41M |
Cash Flow
In the last 12 months, operating cash flow was -20.27M and capital expenditures -1.02M, giving a free cash flow of -21.3M.
Operating Cash Flow | -20.27M |
Capital Expenditures | -1.02M |
Free Cash Flow | -21.3M |
FCF Per Share | -0.87 |
Margins
Gross margin is -498.82%, with operating and profit margins of -14.21K% and -16.65K%.
Gross Margin | -498.82% |
Operating Margin | -14.21K% |
Pretax Margin | -16.65K% |
Profit Margin | -16.65K% |
EBITDA Margin | -15.56K% |
EBIT Margin | -14.21K% |
FCF Margin | -12.53K% |
Dividends & Yields
GNLX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -27.82% |
FCF Yield | -14.79% |
Analyst Forecast
The average price target for GNLX is $17.5, which is 319.7% higher than the current price. The consensus rating is "Buy".
Price Target | $17.5 |
Price Target Difference | 319.7% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Scores
Altman Z-Score | 3.28 |
Piotroski F-Score | 3 |